paclitaxel has been researched along with Corneal Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aicher, SA; Blum, C; Hamity, MV; Hammond, DL; Hegarty, DM; Kolker, SJ; Langmack, L | 1 |
| Holland, SP; Sekhon, A; Tan, JCH; Wang, JYF; Yeung, SN | 1 |
| Hosotani, Y; Mimura, O; Morimatsu, T; Takata, M | 1 |
3 other study(ies) available for paclitaxel and Corneal Diseases
| Article | Year |
|---|---|
Nicotinamide Riboside Alleviates Corneal and Somatic Hypersensitivity Induced by Paclitaxel in Male Rats.
Topics: Animals; Corneal Diseases; Disease Models, Animal; Hypersensitivity; Male; Niacinamide; Paclitaxel; Rats; Rats, Sprague-Dawley; Tears; Vitamin B Complex | 2022 |
Limbal stem cell deficiency secondary to systemic paclitaxel (Taxol) for breast cancer: a case report.
Topics: Aged; Breast Neoplasms; Corneal Diseases; Epithelium, Corneal; Female; Humans; Limbus Corneae; Paclitaxel; Stem Cells | 2020 |
[A Case of a Corneal Disorder after Breast Cancer Treatment with Nab-paclitaxel].
Topics: Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Corneal Diseases; Female; Humans; Middle Aged; Paclitaxel; Trastuzumab; Visual Acuity | 2016 |